Travere Therapeutics, Inc.TVTXNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending higher, below historical average.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-265.77M
↓ 97% below average
Average (9y)
$-134.97M
Historical baseline
Range
High:$129.46M
Low:$-326.25M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-265.77M | +18.5% |
| 2023 | $-326.25M | -9.0% |
| 2022 | $-299.42M | -62.3% |
| 2021 | $-184.46M | -27.1% |
| 2020 | $-145.16M | -35.4% |
| 2019 | $-107.21M | -46.1% |
| 2018 | $-73.39M | -89.8% |
| 2017 | $-38.67M | +0.3% |
| 2016 | $-38.79M | -130.0% |
| 2015 | $129.46M | - |